Open AccessSustained Improvement in Patient-Reported Outcomes with Continued Apremilast Treatment over 104 Weeks in Patients with Moderate to Severe Psoriasis
Author(s) -
Michael Chapman,
Joshua Cirulli,
Sandy McBride
Publication year - 2018
Publication title -
skin the journal of cutaneous medicine
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.2.supp.23
Subject(s) - apremilast , psoriasis , medicine , plaque psoriasis , dermatology , pediatrics , psoriatic arthritis
not available. Disclosures: Study supported by Celgene. Copyright SKIN 2018
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom